サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565674

曝露前予防（PrEP）市場：製品タイプ別、使用タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測

Pre-Exposure Prophylaxis (PrEP) Market, By Product Type, By Usage Type, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
曝露前予防（PrEP）市場：製品タイプ別、使用タイプ別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、2024年～2032年の予測
出版日: 2024年09月04日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

曝露前予防（PrEP）市場規模は2023年に49億8,043万米ドルとなり、2024年から2032年にかけてCAGR 12.30%で拡大

曝露前予防（PrEP）市場-市場力学

PrEPの有効性と入手可能性に関する認識と教育の向上。

PrEPの有効性と入手可能性に関する認識と教育の高まりが、PrEP市場を大きく牽引します。PrEPがどのようにHIVを予防できるかをより多くの人々が理解するにつれて、薬剤に対する需要が高まる。米国疾病対策予防センター（CDC）は、認知度向上キャンペーンがハイリスク集団におけるPrEP使用の大幅な増加につながったと報告しています。

米国疾病予防管理センター（CDC）は、2021年の時点で、HIVリスクの高い人の60％近くがPrEPを知っていると報告しました。CDCはまた、2018年から2021年にかけてPrEPの処方が25％増加したことを指摘しており、これはこの予防治療に対する認識と普及の高まりを反映しています。このような認識と利用の高まりは、PrEP市場拡大の重要な要因です。

曝露前予防（PrEP）市場-主な洞察

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約12.30%のCAGRで毎年成長すると推定されます。

製品タイプ別では、ブランドPrEPが2023年に最大の市場シェアを示すと予測されます。

使用タイプに基づくと、2023年には経口PrEPの1日1回投与が主要タイプでした。

地域別では、北米が2023年に収益でリードしました。

曝露前予防（PrEP）市場-セグメンテーション分析：

世界の曝露前予防（PrEP）市場は、製品タイプ、使用タイプ、エンドユーザー、地域に基づいて区分されます。

市場は、製品タイプに基づいてジェネリックPrEPとブランドPrEPの2つのカテゴリーに分けられます。曝露前予防（PrEP）市場では、現在ブランドPrEP分野が最も優勢です。これは、TruvadaやDescovyのようなブランド製品の市場での存在感と広範なプロモーションによるところが大きいです。ブランドPrEPは、確立されたブランド認知、包括的な臨床サポート、広範な流通網から利益を得ています。また、有効性と安全性が証明されているため、ヘルスケア・プロバイダーから優先的に推奨されることも多いです。対照的に、ジェネリックPrEPsは、入手可能性は増加しているもの、ブランド認知度が低く、包括的なサポートが受けられない可能性があるため、市場シェアを獲得する上で依然として課題に直面しています。

市場は、使用タイプに基づき2つのカテゴリーに分類されます。長時間作用型注射剤露出前予防薬（PrEP）市場では、現在、日用経口PrEP分野が最も優勢です。この優位性は、トゥルバダやデスコビーなどの日局経口PrEPが長年使用され、臨床的に検証されていることに起因しており、これらの薬剤は有効性と安全性において確立された実績を有しています。日経口PrEPは広く入手可能であり、ヘルスケア提供者に受け入れられているため、大きな市場シェアを占めています。長時間作用型の注射剤も台頭してきているが、市場参入が新しく、長期的なデータポイントが少ないため、同レベルの市場浸透には至っていないです。

曝露前予防（PrEP）市場-地理的洞察

曝露前予防（PrEP）市場の最大地域は北米、特に米国です。この地域がリードしているのは、高度な医療インフラ、HIV予防に対する高い意識、公衆衛生イニシアティブによる強力な支援によるものです。米国はまた、PrEP治療薬の研究開発に多額の投資を行っています。さまざまなヘルスケア・プログラムや保険適用によってPrEPを利用できることが、さらにPrEPの普及を後押ししています。北米市場の優位性は、強固な規制の枠組みとPrEPの使用を促進する積極的な支持団体によって支えられています。

曝露前予防（PrEP）市場-競合情勢：

曝露前予防（PrEP）市場は競争が激しく、複数の大手企業が市場を独占しています。Gilead Sciences, Inc.は、PrEP製品であるTruvadaとその新しい製剤であるDescovyでリードしています。ヴィーブヘルスケアは長時間作用型注射PrEPのアプレチュードでこれに続く。ブリストル・マイヤーズスクイブ社とヤンセン・ファーマシューティカルズ社も重要で、現在進行中の研究とPrEP開発の可能性があります。メルク社とアッヴィ社は、HIV研究と新たなPrEPソリューションで貢献しています。Roche社とPfizer社はHIV治療に関わっており、PrEP市場に影響を与えています。Sage TherapeuticsとModerna, Inc.は、新しい予防法を模索している革新的な企業です。Mylan N.V.、Hikma Pharmaceuticals、Cipla Limited、Aurobindo Pharmaは、ジェネリックPrEPの選択肢を提供し、アクセスと手頃な価格を拡大しています。この競合情勢の特徴は、HIVの予防と治療の成果を改善することを目的とした継続的な技術革新と開発です。

目次

第1章 曝露前予防（PrEP）市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 曝露前予防（PrEP）の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 曝露前予防（PrEP）業界調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 曝露前予防（PrEP）市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 曝露前予防（PrEP）市場情勢

  • 曝露前予防（PrEP）市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 曝露前予防（PrEP）市場- 製品タイプ別

  • 概要
    • 製品タイプ別セグメントシェア分析
    • ジェネリック PrEP
    • ブランドPrEP

第8章 曝露前予防（PrEP）市場- 使用タイプ別

  • 概要
    • 使用タイプ別セグメントシェア分析
    • 毎日の経口PrEP
    • 長時間作用型注射剤

第9章 曝露前予防（PrEP）市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院と診療所
    • コミュニティヘルスセンター
    • 専門HIVクリニック

第10章 曝露前予防（PrEP）市場- 地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 曝露前予防（PrEP）業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Gilead Sciences, Inc.
    • ViiV Healthcare
    • Bristol-Myers Squibb
    • Janssen Pharmaceuticals
    • Merck &Co., Inc.
    • AbbVie Inc.
    • Roche
    • Pfizer Inc.
    • Sage Therapeutics
    • Moderna, Inc.
    • Mylan NV
    • Hikma Pharmaceuticals
    • Cipla Limited
    • Aurobindo Pharma

第12章 アナリストの全方位展望

目次
Product Code: ANV3845

REPORT HIGHLIGHT

Pre-Exposure Prophylaxis (PrEP) Market size was valued at USD 4,980.43 Million in 2023, expanding at a CAGR of 12.30% from 2024 to 2032.

Pre-exposure prophylaxis (PrEP) is a preventive treatment for high-risk individuals to reduce HIV infection. It involves taking a daily pill containing antiretroviral drugs. The PrEP market includes developing, manufacturing, and distributing these medications. This market has expanded due to increased HIV prevention awareness and access. Key players include pharmaceutical companies and healthcare providers. Ongoing research aims to improve PrEP options and explore new formulations.

Pre-Exposure Prophylaxis (PrEP) Market- Market Dynamics

Increased awareness and education about PrEP's effectiveness and availability.

Increased awareness and education about PrEP's effectiveness and availability significantly drive the PrEP market. As more people understand how PrEP can prevent HIV, demand for the drug rises. the Centers for Disease Control and Prevention (CDC) reported that increased awareness campaigns led to a substantial rise in PrEP use among high-risk populations.

The U.S. Centers for Disease Control and Prevention (CDC) reported that as of 2021, nearly 60% of individuals at high risk of HIV were aware of PrEP. The CDC also noted a 25% increase in PrEP prescriptions from 2018 to 2021, reflecting this preventive treatment's growing awareness and adoption. This rise in awareness and utilization is a key driver for the expanding PrEP market.

Pre-Exposure Prophylaxis (PrEP) Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.30% over the forecast period (2024-2032)

Based on product type segmentation, branded PrEP was predicted to show maximum market share in the year 2023

Based on Usage Type segmentation, daily oral PrEP was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Pre-Exposure Prophylaxis (PrEP) Market- Segmentation Analysis:

The Global Pre-Exposure Prophylaxis (PrEP) Market is segmented on the basis of Product Type, Usage Type, End User, and Region.

The market is divided into two categories based on product type Generic PrEP, Branded PrEP. In the Pre-Exposure Prophylaxis (PrEP) market, the branded PrEP segment is currently the most dominant. This is largely due to the strong market presence and extensive promotion of branded products like Truvada and Descovy. Branded PrEPs benefit from established brand recognition, comprehensive clinical support, and extensive distribution networks. They also often receive preferential recommendations from healthcare providers due to their proven efficacy and safety profiles. In contrast, generic PrEPs, while increasing in availability, still face challenges in gaining market share due to lower brand recognition and potentially less comprehensive support.

The market is divided into two categories based on the Usage Type Daily Oral PrEP. Long-Acting Injectables In the Pre-Exposure Prophylaxis (PrEP) market, the daily oral PrEP segment is currently the most dominant. This dominance stems from the long-standing use and clinical validation of daily oral PrEP, such as Truvada and Descovy, which have a well-established track record for efficacy and safety. Daily oral PrEP is widely available and accepted by healthcare providers, contributing to its significant market share. Long-acting injectables are emerging but have not yet achieved the same level of market penetration due to newer market entry and fewer long-term data points.

Pre-Exposure Prophylaxis (PrEP) Market- Geographical Insights

The largest region for the Pre-Exposure Prophylaxis (PrEP) market is North America, particularly the United States. This region leads due to its advanced healthcare infrastructure, high awareness of HIV prevention, and strong support from public health initiatives. The U.S. also benefits from significant investments in research and development for PrEP medications. The availability of PrEP through various healthcare programs and insurance coverage further boosts its adoption. North America's market dominance is supported by robust regulatory frameworks and active advocacy groups promoting PrEP usage.

Pre-Exposure Prophylaxis (PrEP) Market- Competitive Landscape:

The Pre-Exposure Prophylaxis (PrEP) market is highly competitive, with several major players dominating the landscape. Gilead Sciences, Inc.leads with its PrEP product, Truvada, and its newer formulation, Descovy. ViiV Healthcare follows with Apretude, a long-acting injectable PrEP option. Bristol-Myers Squibb and Janssen Pharmaceuticals are also significant, with ongoing research and potential PrEP developments. Merck & Co., Inc. and AbbVie Inc. contribute through their HIV research and emerging PrEP solutions. Roche and Pfizer Inc. are involved in HIV treatments, influencing the PrEP market. Sage Therapeutics and Moderna, Inc. are innovative players exploring new prevention methods. Mylan N.V., Hikma Pharmaceuticals, Cipla Limited, and Aurobindo Pharma provide generic PrEP options, expanding access and affordability. This competitive landscape is characterized by continuous innovation and development aimed at improving prevention and treatment outcomes for HIV.

Recent Developments:

In September 2024, with yet another phase 3 victory, Gilead is racing to introduce a long-acting PrEP medication in 2025.

In April 2023, Merck & Co. (MRK.N) said that it will acquire Prometheus Biosciences Inc. (RXDX.O) for approximately $10.8 billion. The acquisition will allow Merck to expand its foothold in immunology and acquire a potential experimental treatment for ulcerative colitis and Crohn's disease.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Gilead Sciences, Inc.
  • ViiV Healthcare
  • Bristol-Myers Squibb
  • Janssen Pharmaceuticals
  • Merck & Co., Inc.
  • AbbVie Inc.
  • Roche
  • Pfizer Inc.
  • Sage Therapeutics
  • Moderna, Inc.
  • Mylan N.V.
  • Hikma Pharmaceuticals
  • Cipla Limited
  • Aurobindo Pharma

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Generic PrEP
  • Branded PrEP

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Daily Oral PrEP
  • Long-Acting Injectables

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Community Health Centers
  • Specialized HIV Clinics

GLOBAL PRE-EXPOSURE PROPHYLAXIS (PREP) MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pre-Exposure Prophylaxis (PrEP) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Product Type
    • 2.1.2. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Usage Type
    • 2.1.3. Pre-Exposure Prophylaxis (PrEP) Market Snippet by End User
    • 2.1.4. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Country
    • 2.1.5. Pre-Exposure Prophylaxis (PrEP) Market Snippet by Region
  • 2.2. Competitive Insights

3. Pre-Exposure Prophylaxis (PrEP) Key Market Trends

  • 3.1. Pre-Exposure Prophylaxis (PrEP) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pre-Exposure Prophylaxis (PrEP) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pre-Exposure Prophylaxis (PrEP) Market Opportunities
  • 3.4. Pre-Exposure Prophylaxis (PrEP) Market Future Trends

4. Pre-Exposure Prophylaxis (PrEP) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pre-Exposure Prophylaxis (PrEP) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pre-Exposure Prophylaxis (PrEP) Market Landscape

  • 6.1. Pre-Exposure Prophylaxis (PrEP) Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pre-Exposure Prophylaxis (PrEP) Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Generic PrEP
    • 7.1.3. Branded PrEP

8. Pre-Exposure Prophylaxis (PrEP) Market - By Usage Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Usage Type, 2023 & 2032 (%)
    • 8.1.2. Daily Oral PrEP
    • 8.1.3. Long-Acting Injectables

9. Pre-Exposure Prophylaxis (PrEP) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Community Health Centers
    • 9.1.4. Specialized HIV Clinics

10. Pre-Exposure Prophylaxis (PrEP) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pre-Exposure Prophylaxis (PrEP) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pre-Exposure Prophylaxis (PrEP) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Gilead Sciences, Inc.
    • 11.2.2. ViiV Healthcare
    • 11.2.3. Bristol-Myers Squibb
    • 11.2.4. Janssen Pharmaceuticals
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. AbbVie Inc.
    • 11.2.7. Roche
    • 11.2.8. Pfizer Inc.
    • 11.2.9. Sage Therapeutics
    • 11.2.10. Moderna, Inc.
    • 11.2.11. Mylan N.V.
    • 11.2.12. Hikma Pharmaceuticals
    • 11.2.13. Cipla Limited
    • 11.2.14. Aurobindo Pharma

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us